Table 5.
Total systemic antimicrobials prescribed by class (WHO ATC classification, 2020).
| ATC Code | Total Systemic Antimicrobials | No (%) | |
|---|---|---|---|
| J01 | Antibacterials for systemic use | 807 | 83.5% |
| P01AB | Nitroimidazole derivatives | 83 | 8.6% |
| P01B | Antimalarials | 29 | 3.0% |
| P01B | 28 | ||
| P01BB | 1 | ||
| J02 | Antimycotics for systemic use | 10 | 1.0% |
| J02AC | |||
| J04 | Antimycobacterials | 10 | 1.0% |
| J04AM | |||
| J05 | Antivirals for systemic use | 20 | 2.1% |
| J05AR | 9 | ||
| J05AF | 6 | ||
| J05AG | 4 | ||
| J05AB | 1 | ||
| A07AA | Intestinal Anti-infectives | 7 | 0.7% |
| D01 | Antifungals for dermatological use | 1 | 0.1% |
| D01BA | |||
| 967 | 100% | ||
P01B: artemisinin and derivatives including combinations, P01BB: biguanides, J02AC: triazole derivatives, J04AM: combinations of drugs for treatment of tuberculosis, J05AR: antivirals for treatment of HIV infections, combinations, J05AF: nucleoside and nucleotide reverse transcriptase inhibitors, J05AG: non-nucleoside reverse transcriptase inhibitors, J05AB: nucleosides and nucleotides excl. reverse transcriptase inhibitors.